A detailed history of Legend Financial Advisors, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Legend Financial Advisors, Inc. holds 7 shares of OGN stock, worth $104. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 25 72.0%
Holding current value
$104
Previous $518,000 74.13%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$18.65 - $23.03 $335 - $414
-18 Reduced 72.0%
7 $134,000
Q2 2024

Jul 26, 2024

BUY
$17.45 - $21.96 $296 - $373
17 Added 212.5%
25 $518,000
Q1 2024

Apr 17, 2024

BUY
$13.78 - $18.8 $82 - $112
6 Added 300.0%
8 $150,000
Q4 2023

Jan 31, 2024

BUY
$10.95 - $17.32 $21 - $34
2 New
2 $29,000
Q1 2023

Apr 26, 2023

SELL
$21.42 - $32.08 $107 - $160
-5 Reduced 33.33%
10 $235,000
Q4 2022

Jan 30, 2023

BUY
$23.31 - $28.61 $139 - $171
6 Added 66.67%
15 $420,000
Q3 2022

Nov 18, 2022

BUY
$23.4 - $34.25 $210 - $308
9 New
9 $199,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.79B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Legend Financial Advisors, Inc. Portfolio

Follow Legend Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legend Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legend Financial Advisors, Inc. with notifications on news.